Reversing the radiation-induced fibro-atrophic process;Réversibilité de la fibroatrophie radio-induite

Revue de Medecine Interne

Volumn 23, Issue 2, 2002, Pages 164-174

  Delanian, S ^a   Lefaix, J L ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b CEA DIF   (France)

Author keywords

Fibrosis; Pentoxifylline; Radiation therapy; TGF ; Tocopherol

Indexed keywords

GROWTH FACTOR; PENTOXIFYLLINE; SUPEROXIDE DISMUTASE; TOCOPHEROL; TRANSFORMING GROWTH FACTOR BETA1;

BONE NECROSIS; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; INFLAMMATION; MYOFIBROBLAST; RADIATION INJURY; REVIEW; TISSUE NECROSIS;

EID: 0036173438     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00532-X     Document Type: Short Survey

References (70)

1. Tolerance of normal tissue to therapeutic irradiation
2. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast
3. Late effects consensus conference RTOG/ EORTC
4. Les radiolésions après irradiation pour cancer du sein
5. La fibrose iatrogénique en cancérologie: Aspects descriptifs et physiopathologiques (a)
6. La fibrose iatrogénique en cancérologie: Principales étiologies et possibilités thérapeuti- ques (b)
7. TGFβ1 levels in pretreatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
8. Tumor recurrence versus fibrosis in the irradiated breast: Differentiation with dynamic gadolinium-enhanced MR imaging
9. Quantitative magnetic resonance for assessment of radiation fibrosis after post-mastectomy radiotherapy
10. Controversy in the MR imaging appearance of fibrosis
11. Modifications du microrelief cutané dans la fibrose radio-induite superficielle: Étude qualitative
12. Normal transcutaneous oxygen pressure in skin after radiation therapy for cancer
13. Acute radiation effects on cutaneous microvasculature: Evaluation with a laser Doppler perfusion monitor
14. Évaluations des modifications radioinduites tardives de la microcirculation superficielle [I] Apport clinique du laser Doppler cutané
15. Dose volume effects on fibrosis after breast cancer conservation therapy
16. Time dose factors in radiotherapy: A review of human data
17. Pronostic factors for acute and late skin reactions in radiotherapy patients
18. Patient to patient variability in the expression of radiation-induced normal tissue injury
19. Major interactions between radiation therapy and systemic sclerosis: Is there an optimal treatment?
20. Acute and late reactions to radiation therapy in patients with collagen vascular diseases
21. Wound healing complications following biopsy of the irradiated breast
22. Complications of combined radiotherapy and chemotherapy
23. Amifostine and radiationtherapy: Past, present, and future
24. Radiosensibililité tumorale et individuelle. Une introduction
25. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy
26. Ataxie télangiectasie et cancer: Une question ouverte
27. Les tests prédictifs de la réponse à la radiothérapie: Bilan et perspectives en 1997
28. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal tissue radiosensitivity?
29. Irradiation gamma et effets tardifs: La fibrose musculaire
30. Diagnosis of acute localized irradiation lesions: A review of the French experimental experience
31. A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis
32. Growth factors in the extracellular matrix
33. Factors influencing myofibroblast differentiation during wound healing and fibrosis
34. Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis
35. Myofibroblasts I. Paracrine cells important in health and disease
36. Abnormal phenotype of human cultured fibroblasts from cutaneous fibrosis induced by therapeutic irradiation
37. Cellular basis of radiation-induced fibrosis
38. Slowed growth of cultured fibroblasts from human radiation wounds
39. Matrix metalloproteinases and tissue inhibitor of metalloproteinase expression in primary pig skin fibroblasts cultures derived from radiation-induced skin fibrosis
40. Cutaneous wound healing
41. Oxygen radicals and signaling
42. Oxidative damage and fibrogenesis
43. Oxygen reactive species and anti-oxidant responses during development: The metabolic paradox of cellular differenciation
44. Modulation of fibroblast proliferation by oxygen free radicals
45. Inflammation and oxidative stress in carcinogenesis
46. Medical aspects of superoxyde dismutase
47. Low levels of reactive oxygen species as modulators of cell function
48. Control of fibroblast growth
49. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue
50. Role of transforming growth factor β in human disease
51. Transforming growth factor-beta in tissue fibrosis
52. TGF-β1 and radiation fibrosis: A master switch and a specific therapeutic target?
53. TGF-β1, collagen I and III gene expression in human skin fibrosis induced by therapeutic irradiation
54. Temporal modulation of TGF-β1 gene expression in pig skin and muscular fibrosis after ionizing radiation
55. D-penicillamine therapy in progressive systemic sclerosis
56. Antiinflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis
57. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation
58. Reduced plasma TGFβ1 levels in patients with chronic hepatitis C after interferon alpha therapy: Association with regression of hepatic fibrosis
59. A preliminary study of long term treatment with inetrferon gamma 1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis
60. Interferon gamma in survivors of the Tchernobyl power plant accident: New therapeutic option for radiation-induced fibrosis
61. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: Clinical trial
62. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study
63. In vitro modulation by liposomal superoxide dismutase of the fibroblast phenotype in human skin with chronic radiotherapy damage
64. Anti-fibrotic action of Cu/Zn SOD is mediated by TGFβ1 repression and phenotypic reversion of myofibroblasts
65. Pentoxifylline in the treatment of radiation-related soft tissue injury: Preliminary observations
66. Alpha-tocopherol treatment of radiofibrosis post-brachytherpy for breast cancer
67. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol
68. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: An experimental study
69. Preliminary study of pentoxifylline in the treatment of late radiation soft tissue necrosis
70. Refractory osteoradionecrosis: Striking healing with combination of pentoxyfilline-tocopherol